Shijiazhuang Huaxu Pharmaceutical

Shijiazhuang Huaxu Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company is a significant global supplier of central nervous system (CNS) medications, with a particular focus on gabapentinoids such as Gabapentin and Pregabalin. Operating out of Shijiazhuang, a major industrial hub for the Chinese life sciences sector, Huaxu Pharmaceutical maintains modern manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards. Its business model encompasses both the sale of proprietary generic APIs and the provision of contract manufacturing (CMO) services for global pharmaceutical partners. The company's products are exported to numerous international markets, including North America, Europe, and Southeast Asia.